Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1869971

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1869971

Hemorrhoids Treatment Market Size, Share & Trends Analysis Report By Disease (Internal Hemorrhoids, External Hemorrhoids), By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Hemorrhoids Treatment Market Summary

The global hemorrhoids treatment market size was estimated at USD 762.99 million in 2024 and is projected to reach USD 1,465.28 million by 2033, growing at a CAGR of 7.5% from 2025 to 2033. The increasing prevalence of hemorrhoidal disorders is driving market growth, influenced by sedentary lifestyles, poor diets, rising obesity, and aging, which reduces tissue elasticity.

For instance, in December 2024, Journal of Disease and Global Health reported that 50% to 85% of the global population experienced hemorrhoids in their lifetime, with one-quarter of Africans over 50 affected. The study noted 3.3 million U.S. ambulatory-care visits, making hemorrhoids the fourth most common gastrointestinal disorder in outpatient settings. Mild to moderate cases were managed with fiber, hydration, and sitz baths, while severe cases used rubber band ligation, sclerotherapy, or infrared coagulation. Advanced cases required stapled hemorrhoidopexy or artery ligation, with postoperative care addressing pain, bleeding, and urinary retention. Greater awareness and diagnostic advances are driving timely interventions and treatment demand.

Technological innovations in hemorrhoid treatment methods are transforming patient care and supporting market expansion. Minimally invasive procedures, such as rubber band ligation, infrared coagulation, and laser therapy, offer faster recovery, reduced pain, and minimal complications, attracting more patients. Advanced topical formulations and oral medications improve symptom management and enhance patient adherence, while innovative combination therapies address multiple aspects of the disorder. For instance, in June 2024, Korea Biomedical Review reported that over 80% of the global population experiences hemorrhoids at some point, particularly individuals aged 45 to 65, with prevalence exceeding 50% in those over 50. The article emphasized early diagnosis, appropriate treatment strategies, and lifestyle modifications, including dietary changes and exercise, to manage and prevent complications. Clinics and hospitals increasingly implement these procedures to optimize outcomes and efficiency, reducing hospital stays and post-treatment follow-up requirements. Continuous improvements in treatment delivery and procedural techniques encourage wider adoption of these therapies, fostering growth across both developed and emerging markets globally.

Consumer demand for convenient, effective, and accessible hemorrhoid treatments is fueling market growth further. Over-the-counter ointments, suppositories, and oral supplements provide patients with practical options for self-care at home, while increasing awareness of lifestyle interventions encourages proactive symptom management. Marketing campaigns, educational initiatives, and digital platforms highlight the advantages and ease of use of modern treatments, enhancing patient engagement. Expanding distribution channels, including pharmacies, specialty clinics, and e-commerce platforms, ensure wider availability and accessibility. As patients increasingly prefer safe, minimally invasive, and home-based treatment solutions, manufacturers and healthcare providers continue to innovate, introducing new products and therapeutic options that meet evolving consumer expectations and needs.

Global Hemorrhoids Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemorrhoids treatment market report based on disease, drug class, distribution channel, and region:

  • Disease Outlook (Revenue, USD Million, 2021 - 2033)
  • Internal Hemorrhoids
  • External Hemorrhoids
  • Mixed Hemorrhoids
  • Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
  • Corticosteroids
  • Local Anesthetics
  • Vasoconstrictors
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Product Code: GVR-4-68040-783-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Drug Class
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hemorrhoids Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Pricing Analysis

Chapter 4. Hemorrhoids Treatment Market: Disease Business Analysis

  • 4.1. Disease Market Share, 2024 & 2033
  • 4.2. Disease Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
  • 4.4. Internal Hemorrhoids
    • 4.4.1. Internal Hemorrhoids Market, 2021 - 2033 (USD Million)
  • 4.5. External Hemorrhoids
    • 4.5.1. External Hemorrhoids Market, 2021 - 2033 (USD Million)
  • 4.6. Mixed Hemorrhoids
    • 4.6.1. Mixed Hemorrhoids Market, 2021 - 2033 (USD Million)

Chapter 5. Hemorrhoids Treatment Market: Drug Class Business Analysis

  • 5.1. Drug Class Market Share, 2024 & 2033
  • 5.2. Drug Class Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 5.4. Corticosteroids
    • 5.4.1. Corticosteroids Market, 2021 - 2033 (USD Million)
  • 5.5. Local Anesthetics
    • 5.5.1. Local Anesthetics Market, 2021 - 2033 (USD Million)
  • 5.6. Vasoconstrictors
    • 5.6.1. Vasoconstrictors Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Hemorrhoids Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2033
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Online Pharmacy
    • 6.4.1. Online Pharmacy Market, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacy
    • 6.5.1. Retail Pharmacy Market, 2021 - 2033 (USD Million)
  • 6.6. Hospital Pharmacy
    • 6.6.1. Hospital Pharmacy Market, 2021 - 2033 (USD Million)

Chapter 7. Hemorrhoids Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Hemorrhoids Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. Uk Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Lupin
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Cipla
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Amato Pharmaceutical Products, Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Church & Dwight Co., Inc
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Haleon Group of Companies
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Sebela Pharmaceuticals
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Bayer AG
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Sanofi
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Abbott
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sun Pharmaceutical Industries, Inc
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
Product Code: GVR-4-68040-783-7

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global hemorrhoids treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 5. Global hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 6. Global hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7. North America hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 8. North America hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 9. North America hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 10. North America hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11. U.S. hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 12. U.S. hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 13. U.S. hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 14. Canada hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 15. Canada hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 16. Canada hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 17. Mexico hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 18. Mexico hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 19. Mexico hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20. Europe hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 21. Europe hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 22. Europe hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 23. Europe hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24. UK hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 25. UK hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 26. UK hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 27. Germany hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 28. Germany hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 29. Germany hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30. France hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 31. France hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 32. France hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 33. Italy hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 34. Italy hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 35. Italy hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 36. Spain hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 37. Spain hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 38. Spain hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39. Norway hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 40. Norway hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 41. Norway hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 42. Denmark hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 43. Denmark hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 44. Denmark hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45. Sweden hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 46. Sweden hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 47. Sweden hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD
  • Table 52. Japan hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 53. Japan hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 54. Japan hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 55. China hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 56. China hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 57. China hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 58. India hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 59. India hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 60. India hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61. Australia hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 62. Australia hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 63. Australia hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 64. South Korea hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 65. South Korea hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 66. South Korea hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 67. Thailand hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 68. Thailand hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 69. Thailand hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70. Latin America hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 71. Latin America hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 72. Latin America hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 73. Latin America hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 74. Brazil hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 75. Brazil hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 76. Brazil hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 77. Argentina hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 78. Argentina hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 79. Argentina hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 83. Middle East & Africa hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 84. South Africa hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 85. South Africa hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 86. South Africa hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 90. UAE hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 91. UAE hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 92. UAE hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 93. Kuwait hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 94. Kuwait hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 95. Kuwait hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hemorrhoids treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Hemorrhoids treatment market dynamics
  • Fig. 12 Hemorrhoids treatment market: Porter's five forces analysis
  • Fig. 13 Hemorrhoids treatment market: PESTLE analysis
  • Fig. 14 Disease market, 2021 - 2033 (USD Million)
  • Fig. 15 Internal Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 16 External Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 17 Mixed Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 18 Drug Class market, 2021 - 2033 (USD Million)
  • Fig. 19 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 20 Local Anesthetics market, 2021 - 2033 (USD Million)
  • Fig. 21 Vasoconstrictors market, 2021 - 2033 (USD Million)
  • Fig. 22 Others market, 2021 - 2033 (USD Million)
  • Fig. 23 Distribution channel market, 2021 - 2033 (USD Million)
  • Fig. 24 Online pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 25 Retail pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 26 Hospital pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 27 Hemorrhoids treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 MEA hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!